Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial update for Chiauranib in advanced hepatocellular carcinoma has completed recruitment.
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Toripalimab Plus Sorafenib in Patients With Advanced-Stage Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating toripalimab in combination with sorafenib for advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating SBRT in combination with durvalumab for inoperable/unresectable hepatocellular carcinoma is ongoing; sta…
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma [Phase 3]
Phase 3 trial update for Doxorubicin Transdrug in advanced hepatocellular carcinoma shows completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study [Phase 2, Phase 3]
A single-arm study evaluating the combination of transarterial chemoembolization (TACE), lenvatinib, and camrelizumab for BCLC stage B/C hep…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: TQB2450 Combined With Anlotinib Hydrochloride in the Perioperative Treatment of Hepatocellular Carcinoma Hydrochloride Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With a High Risk of Recurrence or Metastasis [Phase 1, Phase 2]
Clinical trial update for TQB2450 plus anlotinib hydrochloride as neoadjuvant therapy in resectable hepatocellular carcinoma at high risk of…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]
A Phase 1/2 trial assessing CC-122 in combination with nivolumab for unresectable hepatocellular carcinoma has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC [Phase 4]
Phase 4 trial update on pharmacological manipulation of intrahepatic arterial blood flow in hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Transarterial Infusion of PD-1 Antibody Plus TACE-HAIC for Unresectable HCC: a Single-arm, Phase 2 Clinical Trial [Phase 2]
A single-arm Phase 2 clinical trial evaluating transarterial infusion of a PD-1 antibody combined with TACE-HAIC for unresectable hepatocell…
-
CLINICAL_TRIALS trial_result · 2021-04-20Clinical Trial Update: A Neoadjuvant Hepatocellular Carcinoma Study of Camrelizumab in Combination With Apatinib and Oxaliplatin [Phase 2]
Phase 2 neoadjuvant trial evaluating camrelizumab plus apatinib and oxaliplatin for resectable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: Sharing Decision-making Program for HCC Patients Treatment Decisions [NA]
A completed clinical trial evaluating a Shared Decision-Making Program for treatment decisions in patients with hepatocellular cancer.
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCC [Phase 1, Phase 2]
Early-phase trial investigating sintilimab plus a bevacizumab biosimilar for potentially resectable intermediate hepatocellular carcinoma (P…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer [Phase 2]
Phase 2 trial evaluating CS1008 in combination with sorafenib versus sorafenib alone in advanced liver cancer has completed recruitment with…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 trial of refametinib in RAS mutant hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma [Phase 1, Phase 2]
A clinical trial evaluating E7050 plus sorafenib versus sorafenib alone as first-line therapy in hepatocellular carcinoma has completed, wit…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Tislelizumab Combined With Lenvatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating tislelizumab in combination with lenvatinib as perioperative therapy for resectable hepatocellular carcinoma; statu…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC) [Phase 2]
A Phase 2 trial evaluating refametinib in combination with sorafenib in RAS-mutant hepatocellular carcinoma has been completed.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer [Phase 1, Phase 2]
Phase 1/2 study of sacituzumab govitecan-hziy (IMMU-132) in adults with epithelial cancers; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: A Study of Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs). [Phase 2]
Phase 2 study evaluating camrelizumab combined with apatinib in hepatocellular carcinoma patients previously treated with immune checkpoint …
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC
Prospective study assessing safety of Deb-TACE with 100µ beads in patients with non-resectable hepatocellular carcinoma; completed with post…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer [Phase 2]
Phase 2 trial update on T cell receptor immunotherapy targeting NY-ESO-1 in NY-ESO-1 expressing cancers; study is completed with results pos…
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01) [Phase 2, Phase 3]
Clinical trial update on combining sintilimab with stereotactic body radiotherapy (SBRT) in hepatocellular carcinoma (HCC) across Phase 2 an…
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Transarterial Embolization Alone Versus Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma [Phase 3]
Phase 3 trial comparing transarterial embolization alone to drug-eluting beads chemoembolization for hepatocellular carcinoma is in progress…
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment [Phase 2]
Phase II trial of avelumab in advanced hepatocellular carcinoma after prior sorafenib treatment has been completed.
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Thermal Ablation Combined With Anlotinib and TQB2450 Solution for HCC [Phase 3]
Phase 3 trial evaluating thermal ablation combined with anlotinib and TQB2450 (PD-L1 inhibitor) for hepatocellular carcinoma.